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Abstract: Maternal smoking during pregnancy is a major public health problem that has 
been associated with numerous short- and long-term adverse health outcomes in offspring. 
However, characterizing smoking exposure during pregnancy precisely has been rather 
difficult: self-reported measures of smoking often suffer from recall bias, deliberate 
misreporting, and selective non-disclosure, while single bioassay measures of nicotine 
metabolites only reflect recent smoking history and cannot capture the fluctuating and 
complex patterns of varying exposure of the fetus. Recently, Dukic et al. [1] have proposed 
a statistical method for combining information from both sources in order to increase the 
precision of the exposure measurement and power to detect more subtle effects of smoking. 
In this paper, we extend the Dukic et al. [1] method to incorporate individual variation of 
the metabolic parameters (such as clearance rates) into the calibration model of smoking 
exposure during pregnancy. We apply the new method to the Family Health and 
Development Project (FHDP), a small convenience sample of 96 predominantly working-
class white pregnant women oversampled for smoking. We find that, on average, 
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misreporters smoke 7.5 cigarettes more than what they report to smoke, with about one third 
underreporting by 1.5, one third under-reporting by about 6.5, and one third underreporting 
by 8.5 cigarettes. Partly due to the limited demographic heterogeneity in the FHDP sample, 
the results are similar to those obtained by the deterministic calibration model, whose 
adjustments were slightly lower (by 0.5 cigarettes on average). The new results are also, as 
expected, less sensitive to assumed values of cotinine half-life. 
Keywords: smoking; self-report; bioassay; calibration 
 
 
1. Introduction 
 
Maternal smoking during pregnancy is a major public health problem that has been associated with 
numerous short- and long-term adverse health outcomes in offspring [2-5]. Infants who were 
prenatally exposed to maternal cigarette smoke are at increased risk of low birth weight, preterm 
delivery, fetal growth restriction and perinatal mortality [2,6-8]. Although the adverse perinatal (e.g., 
premature birth, low birth weight) effects of maternal smoking and in-utero fetal exposure have been 
well-known for some time, a growing body of literature points to evidence for long-term and 
intergenerational health consequences for children. Furthermore, there is increasing evidence of long-
term behavioral sequelae of exposure, with a robust association to conduct problems in offspring [9-
11], including evidence of gene-exposure interaction [12,13]. Although maternal smoking has 
systematically declined over the 1990s, recent national vital statistics reports suggest that 12.3% of 
women still smoke during pregnancy [14]. Smoking prevalence varies widely by region, ethnicity, age 
and socioeconomic status, ranging from 3-42% [14,15]. In addition, pregnant women are increasingly 
more aware that smoking may be harmful to their offspring, and are also aware of social pressures to 
quit [16], so substantial fluctuations in smoking behavior can occur [17,18].  
Assessing prenatal exposure to cigarette smoke, like assessing other addictive behaviors, is 
challenging. The existing methods imperfectly capture “true” exposure, which is the complex result of 
maternal behavior, smoking topography (dose) and metabolism. However, the accuracy of 
measurement is crucial for studies of long-term effects of exposure on behavior where effects are 
subtle, complex and long-term.  
Smoking behavior during pregnancy has traditionally been assessed either through self-report or 
biologic measures of nicotine metabolites (such as cotinine). Self-report is efficient and low cost and it 
uniquely captures information about historical patterns of smoking. However, self-report is prone to 
biases such as under-reporting due to social pressures and recall bias [19]. Furthermore, variations in 
smoking topography will translate into different amounts of exposure since the same self-reported 
number of cigarettes smoked does not generally correspond to the same amount of inhaled smoke. On 
the other hand, biologic assays provide unique information about individual intake of smoking 
constituents and thus are generally considered more accurate measures of smoking. However, assays 
reflect exposure only over a relatively recent short period (three days or less in pregnancy [20]. 
Similarly, variations in nicotine metabolism across individuals and during pregnancy will result in 
elimination of nicotine and its metabolites at different rates, and consequently in different net exposure Int. J. Environ. Res. Public Health 2009, 6          
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to fetus. Thus, since both self-report and bioassays contribute unique information and error to the 
assessment of exposure, combining the two is likely to enhance precision, and allow us to calibrate 
maternal self-report based on smoking topography and metabolism of cigarette smoke.  
Recently Dukic et al. [1] proposed a “best estimate” method to mathematically combine self-
reported and biologic exposure measures. This method describes the average relationship between 
urine cotinine (taking into account its exponential decay [20,21] and the number of reported cigarettes 
in a sample of pregnant women. Based on this average relationship, which is a combination of 
population characteristics and the characteristics of the sample, this model uses the cotinine 
measurements to ``probabilistically correct” the self-report. It also provides a classification of women 
into “reporting categories”, such as accurate reporters, underreporters, and extreme underreporters. 
Using this method in the Family Health and Development Project (FHDP), we found that on average, 
misreporters smoked about 8 cigarettes more than what they reported to smoke, with about one third 
underreporting by 1.5, one third under-reporting by about 6.5, and one third underreporting by 9 
cigarettes [1]. While this method did allow us to calibrate the self-report, it did that using the same 
algorithm and metabolic parameters for all women. Given that women may differ in how quickly they 
metabolize nicotine, especially during pregnancy, deterministic method may be a bit too inflexible in 
its calibration. Uncertainty due to variation among women in the sample can be reflected in the final 
classifications and adjustments. Given that we are working with a non-linear relationship, this 
uncertainty could propagate into final classifications in non-obvious ways, appearing either as under- 
or over-correction.  
In this paper we thus propose an extension of the Dukic et al. [1] method for combining biological 
and self-reported measures that can also take into account the metabolic heterogeneity among women 
and over the course of the pregnancy. This extension allows us to capture mother-specific relationships 
between her own cotinine metabolism and self-report, which could change over trimesters, reflecting 
the accelerated metabolism during pregnancy. In other words, there are two sources of extra variability 
that the deterministic method did not account for: one is a woman’s own rate of nicotine metabolism, 
and the other is that rate of metabolism may vary in general for all women across the trimesters due to 
pregnancy. We use a Monte Carlo (MC) scheme to capture this additional randomness in a non-linear 
way, and obtain a better estimate of fetal exposure (and amount of misreporting) when metabolic 
differences exist.  
 
2. Methods 
 
Data. The data for this study are derived from The Family Health and Development Project (FHDP) 
(for details see [11,17,22]), a small convenience sample of 96 pregnant women oversampled for 
smoking and followed from early pregnancy through their infants’ 24-month birthdays. The sample 
consisted predominantly of non-Hispanic white, working-class pregnant women with high school 
education and low-to-moderate family income. Among them, 51 were non-smokers and 45 were 
smokers. All women were over 18 years of age, with the mean age among non-smokers of 28.9 years 
(standard deviation 5.6) and the mean age of smokers of 26.9 years (standard deviation 5.6). The study 
was approved by the IRB at the University of Chicago. Int. J. Environ. Res. Public Health 2009, 6          
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In this paper we analyze data only from those 45 women in FHDP sample who smoked during 
pregnancy. Most women had one visit per trimester. At each visit, urine samples were collected. Gas 
chromatography-mass spectrometry (GCMS) analyses were conducted to assess cotinine 
concentrations [23]. Maternal self-reported smoking was assessed at each visit in terms of weekday 
and weekend smoking in each month. These detailed self-report data were summarized by the mean 
daily number of cigarettes smoked in each trimester. In addition, self-reported number of cigarettes 
over each of the three days prior to the interview visit was recorded, as were the time of the interview 
and urine collection, and the mothers’ typical daily smoking pattern [19]. 
Deterministic Method. Under the assumptions of constant nicotine metabolism throughout 
pregnancy and no between-women metabolic differences (including similar amount, concentration and 
frequency of urination), Dukic et al. [1] were able to combine the self-report and cotinine smoking 
measures according to the deterministic laws of cotinine metabolism, and obtain a better overall 
measure of smoking exposure (the “corrected self-report”). However this simplifying homogeneity 
assumption may be unrealistic, as the variation among women and over time during pregnancy may be 
quite large.  
More specifically, the method of Dukic et al. [1] is based on the mathematical model of decay of a 
nicotine metabolite (bioassay cotinine) in the body to adjust the self-report of smoking. The key idea in 
this model was the scale alignment. This involves first re-scaling the self-reported number of cigarettes 
so that they correspond to the same underlying scale as cotinine. This is because the cotinine in the 
body (and serum, saliva, or urine) reflects all cigarettes smoked over a certain period of time; however, 
not all cigarettes in that time period are equally represented. Since the amount of cotinine from each 
cigarette decays exponentially over time, the cigarettes smoked further in the past are not represented 
as heavily in the cotinine measure as those smoked more recently.  
Thus, simply comparing the self-reported number of cigarettes (multiplied by a cotinine/cigarette 
conversion factor) to the direct cotinine reading would be erroneous, as they are not on the same scale. 
However, once the scales for the two measures are aligned, we can compare and combine them. The 
calibration of the self-report is then done based on the percentiles of the expected distribution of 
discrepancies between weighted self-report and cotinine. 
Monte Carlo Method. Using a Monte Carlo method, we will extend the above approach to draw on: 
(a) individual mothers' patterns in repeated urine cotinine measurements over the course of pregnancy, 
(b) sample level data on the correspondence of self-reported smoking and cotinine levels, and, (c) 
information from independent experimental studies about the variability in the biological parameters 
driving the metabolism of nicotine during the course of the pregnancy. These three sources of 
information allow us to model woman-specific and trimester-specific factors (small but consistent 
deviations from the “average” metabolism over time). As a result, we will have a Monte Carlo sample 
of reporting classifications for each woman, reflecting the variation in classifications due to variations 
among women and over time.  
Mathematically, the basic model is as follows. At any given point in time, a fraction of nicotine 
from each cigarette is converted into cotinine in the liver and released into the bloodstream. From 
there, a portion is excreted through the kidneys into urine. Once a woman voids, all the cotinine that 
has accumulated in her urine is expelled, and it starts to accumulate anew. The cotinine concentration 
in the blood decays exponentially with a median half-life of approximately nine hours [20], and after Int. J. Environ. Res. Public Health 2009, 6          
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being filtered through the kidneys is deposited in the urine. Thus the amount of urine cotinine consists 
of what has been accumulated between the last time the woman voided and the time of the urine 
sample. Based on this, we can calculate the fraction (or mathematical “weight”) of cotinine from each 
particular cigarette present in the collected urine sample (assuming each cigarette is equal). This 
amount is the difference between the amount of cotinine that would have accumulated in the urine 
sample had the woman not voided at all previously, and the amount of cotinine from that cigarette 
which was accumulated up to, and then expelled at the time of her last voiding. This quantity depends 
on the half-life of cotinine decay in blood and the blood-urine conversion factor, as well as how 
recently the cigarette was smoked relative to the time of collection of the urine sample. All cigarette 
weights are added into the total weighted sum, resulting in the “net present value” of all cigarettes 
smoked over the three days prior to urine collection. As the last step, the measured cotinine 
concentration is converted into the number of these weighted cigarette equivalents, according to the 
steady state cotinine-per-cigarette ratio.  
Dukic et al. [1] examined three different weighting scenarios based on how detailed the available 
information about timing of each cigarette was: (1) morning urine collection, with only average 
cigarettes per day reported; (2) urine collected during the interview with limited information about 
daily pattern of smoking; (3) urine collected during the interview using all information about pattern of 
daily smoking. They found little difference in the FHDP sample between the “uniform” cigarette 
smoking pattern (scenarios 1 and 2) and the actual reported daily pattern (scenario 3) based on the 
detailed FHDP survey. Detailed description of the algorithm used to derive the weights is available in 
the Appendix in [1]. Note that a substantial problem with this and many other datasets is the lack the 
actual times of voiding; it has been suggested by Dukic et al. [1] that in order to obtain more accurate 
alignment between urine-based biological and self-report measures in the future, the interviewers 
should record voiding times as well as smoking patterns of women in future studies. Serum and saliva 
cotinine measures should not suffer from this problem.  
All aspects of cotinine metabolism in the model considered in [1] were assumed to be constant 
across women. While this was an improvement over single-measure approaches, it does not capture 
meaningful individual variation. One way to account for inter-woman variability (heterogeneity) is to 
allow each woman-specific parameter to come from a population distribution. This is what is 
commonly referred to as the random effect or multi-level modeling in statistical literature [24]. If there 
is heterogeneity present, classifications resulting from the random-effect model will properly reflect 
the overall uncertainty associated with the nicotine and cotinine metabolic processes, and will protect 
from over-correcting. However, random effect models can be sensitive to the specified distributional 
assumptions. Thus, we rely on the extensive expertise of the co-author on the metabolism of pregnancy 
smoking to elicit the distributional ranges for the woman-specific effects.  
Smoking metabolism parameters. According to previous research done by Shiffman and colleagues 
[25], the average serum cotinine that is generated per cigarette smoked in general white and Hispanic 
population of light smokers is 12.5 ng/mL, also confirmed by studies of heavier smokers [26-29]. In 
addition, there is evidence that during pregnancy urinary cotinine levels are on average eight times 
higher than serum cotinine [29]. This implies about 100 ng/mL of urinary cotinine per cigarette. If we 
assume that every woman deviates from an “average woman” by a random amount due to unobserved 
differences in metabolism, smoking topography, and urination schedule, the resulting discrepancies Int. J. Environ. Res. Public Health 2009, 6          
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between the self-report and biological measures will also be randomly distributed according to some 
resulting distribution. Our objective thus is to obtain this resulting distribution via a Monte Carlo 
simulation, and to base our classification probabilistically on where on this distribution each woman’s 
discrepancy lies with respect to the combined sample and expert information. 
In addition to these individual woman-specific differences, it is reasonable to expect that 
metabolism changes over time during pregnancy. One theory postulates that the metabolism increases 
with time during pregnancy; Dukic et al. [1] have also observed an increasing trend in the average 
magnitude of discrepancies over time. We however do not measure these metabolic changes in our 
study, and thus the only way we could account for this variability is through a model which allows 
each trimester to have a trimester-specific effect. Thus, the woman-specific effects are designed to 
capture the effect of all unobserved differences among women’s metabolisms, body size, propensity  
to mis-report, but they stay the same for each woman over all three trimesters. The trimester effect on 
the other hand would be designed to reflect systematic differences due to average (across women) 
metabolic differences among trimesters. In order to account for both of these unobserved processes, we 
thus extend the Dukic et al. [1] model to include woman-specific effects (characterized by 
distributions of woman-specific cotinine half-lives and the extracted amounts of cotinine per cigarette), 
as well as trimester-specific effects.  
The distribution of woman-specific cotinine half-lives is based on the data provided by the previous 
experiments and literature [20,26-29]: we treat the half-life time for each woman i  hw_i , where  
(i = 1, ... ,45), from a normal distribution with mean 8.78 hours and standard deviation 1.67 hours. 
These data were taken from a study of nicotine and cotinine metabolism in pregnant women [20]. The 
trimester effect is assumed to modify each woman’s half-life parameter by a different amount in each 
trimester, but those amounts are assumed to be the same for all women. Due to lack of strong theory 
about shape of metabolic trends over pregnancy, we assume that these deviations are also normally 
distributed with a mean of zero, and the standard deviation equal to the standard deviation of the 
women effects. We denote the trimester effect by ht_j where j = 1, 2, 3, and then the cotinine half-life 
for a woman i in trimester j is obtained by adding the two effects: hw_ij= hw_i + ht_j. We repeat this 
procedure 200 times, yielding 200 woman-trimester specific cotinine half-lives.  
Next, in order to generate a woman-specific effect for the average amount of cotinine generated by 
a single cigarette, we generate a random variable cw_i by forming a product of two other normal 
variables: the blood-urine conversion factor generated from a Normal distribution with a mean of 8 
and standard deviation of 0.5 (N(8,0.5)), and the serum-cotinine-per-cigarette from a Normal 
distribution with mean 12.5 and standard deviation of 2 (N(12.5,2)). These Normal distributions were 
chosen again based on expert advice, and they reflect the experimental ranges of the ratio of cotinine in 
urine to cotinine in blood, of and the cotinine per cigarette in blood, respectively. We assume again 
that trimester effects are normally distributed with mean zero and standard deviation equal to the 
standard deviation of woman-specific effects. The equality of standard deviation is somewhat 
arbitrary, but reflecting the belief that deviations across time are on the same scale as deviations from 
woman to woman. Again, we generate the cotinine per cigarette amount for a woman i in trimester j by 
adding her individual and trimester effect, like we did for half-lives.  
After we generate the sample of 200 woman-trimester specific half-lives and the amounts of 
cotinine per cigarette, for each woman and for all three trimesters, we apply the Dukic et al. [1] Int. J. Environ. Res. Public Health 2009, 6          
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classification thresholds to classify each woman based on each of the 200 differences between the 
weighted sum and cotinine-derived cigarettes. This way, for each woman we get 200 classifications 
into over-reporters, accurate reporters, under-reporters, and extreme under-reporters, in every 
trimester. We adopt a convention that if in any given trimester a woman has at least 50% 
classifications that are the same (over-reporter, accurate reporter, under-reporter or extreme under-
reporter), that category is chosen as that woman’s final classification for that trimester. If the 
classification is unclear, we would check whether the number of classifications that fall into the under 
and extreme under-reporter category jointly make up more than 50% of that woman’s classifications; if 
yes, we classify that woman as under-reporter, and if not, we classify her as an accurate reporter. (Note 
that unlike nondisclosure, over-reporting is rarely encountered in practice. But we still allow for this 
possibility, suspecting this classification is most likely due to deficient conversion of nicotine to 
cotinine, unusually rapid metabolism cotinine or very light smoking topography.) 
 
3. Results: Classification and Calibration of Self-Report 
 
The results of MC classifications of each woman in our sample, by trimester, and under each 
cigarette imputing scenario considered in [1], are summarized in Table 1. The results are very similar 
to the findings based on the original deterministic approach. In particular, the actual classifications are 
quite robust – only the average adjustments appear slightly larger in the Monte Carlo approach due to 
the non-linear nature of adjustments. Such small differences between the MC and deterministic 
methods are possibly due to the small sample size, as well as low demographic heterogeneity in the 
FHDP sample (mostly composed of white working-class younger women). Furthermore, as expected 
based on the findings of [1], all three scenarios are similar, in that the under-reporters seem to under-
report between 6.5 and 8 cigarettes on average, while extreme under-reporters misreport by between 8 
and 11 cigarettes. Little difference between the results obtained under scenarios 2 and 3 again implies 
that the self-reported pattern of smoking may not have much value in these analyses, likely because of 
so few smokers in the sample and the large uncertainty due to voiding and hydration schedules. We 
thus report only the results based on the Scenario 3 which takes advantage of the full daily smoking 
pattern data. 
We also examine the consistency of classification status, defining consistency as “having the same 
status for all pregnancy visits”. Out of 45 smokers in the FHDP dataset, we find that slightly less than 
half of the women have a consistent classification status and 55% of women fluctuate in their 
classification across visits. Of the 45% who are consistent, 20% women are consistent extreme under-
reporters, 11% are consistent under-reporters, 14% consistently report accurately, 0% of women 
consistently over-report. Table 2 summarizes the classification of each woman in each trimester, her 
average trimester self-report, cotinine, and finally the corrected trimester average, using the weighting 
schemes from the third scenario. 
 Int. J. Environ. Res. Public Health 2009, 6          
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Table 1. Classification of women based on the individual MC corrections. For each 
category, the first column (“n”) is the number of women in that classification group. The 
second column (“mean”) is the mean of the differences between the weighted self-report 
and the number of cigarettes from cotinine. The third column (“sd”) is the standard 
deviation of these differences. 
Scen. Trim. 
Category 
over reporting  accurate reporting  under reporting  extreme under 
reporting 
freq  mean sd  n mean sd  n mean sd  n  mean  sd 
1 1 - - -  13  -1.39  3.24  12  -7.92  5.31  13  -8.81  6.18 
1  2  2  2.55  1.98 18 -1.06  2.22 13 -6.62  3.37 12 -8.42 4.34 
1 3 - - -  15  -0.99  1.67  11  -5.85  3.16  15  -8.27  5.81 
2 1 - - - 9  -2.28  1.76  14  -7.51  5.23  15  -10.15  6.34 
2 2 - - -  14  -1.84  2.71  17  -6.80  3.70  14  -9.52  4.83 
2 3 - - -  11  -2.13  1.79  13  -6.47  3.77  17  -8.69  5.96 
3 1 - - -  10  -1.90  1.78  16  -6.48  4.71  12  -11.24  6.44 
3  2  1  3.26  -  17 -1.95  2.15 15 -7.59  3.55 12  -8.88 4.76 
3 3 - - -  13  -1.21  1.30  13  -7.13  3.80  15  -8.04  5.82 
 
Table 2. Classification of women based on the individual MC corrections, under scenario 
3. For each trimester, the first column (“Mean self-report”) shows the self-reported 
trimester daily average number of cigarettes. The second column (“Cot”) shows the 
cotinine level from the urine test in the given trimester. The third column (“Class”) shows 
the classification of the woman: O for over-reporter, A for accurate reporter, U for under-
reporter, and E for extreme under-reporter. The fourth column (“Corrected self-rep”) 
shows the corrected average trimester self-report. No adjustment could be calculated for 
women with missing cotinine measurements. 
 ID  Trimester 1  Trimester 2  Trimester 3 
  
Mean 
self-
rep 
Cot 
(ng 
/mL) 
Class Corrected 
self-rep 
Mean 
self-
rep 
Cot 
(ng 
/mL) 
Class Corrected 
self-rep 
Mean 
self-rep 
Cot 
(ng 
/mL) 
Class Corrected 
self-rep 
1 10  509  A  13.29 8.67  543  A  11.38  10 1280  E  20.77 
2 9.67  254 A  11.19  8  175 A  9.20  4  170 A  5.04 
4  2 547  E  6.25  1 342  E  4.50  3  199  U  5.01 
8  18.67  1130  U 26.97 20  1240  U 30.51  19  506  A 20.58 
10 9.33 366  A  12.34  4  507  U  7.43  7  1230 E  19.01 
11  13 1270 U  22.69  10 1840 E  26.76  12  2010 E  29.24 
12  20  1670  U  31.61  20  1340  U  29.74  20          
13  0.09  61.5 E  0.54  0  0  A  0.00  0.5  57.9 E  1.19 
19 13.33  1680  E  26.61  11.67 655  A  15.76  10  1020  U  16.99 
20 13.67  1840  E  28.11  15  1570  U  27.73  14  776  U  19.90 
22  8.67  769 U  13.78  13 784 U  18.21  7.5  550 A  7.79 
26  10  1110  U 18.93  13.33  1260  U 23.65 15.5  997  U 21.36 
31  0  33  U 0.38  0  10.7  A 0.11  0  61.6  U 0.69 
35  6  1480 E  17.54  5  793  E  12.77  4.5  1130 E  13.28 
38 0 596  E  6.05  0 632  E  6.31  0  319  E  3.23 
41 20 266 A  18.75  23.33  704 A  26.63  20  490 A  22.44 
47  10 1280 E  19.22  10 1100 U  17.15  10  991 U  16.42 
48 9  1020  E  17.89 12.33  64.4  O  8.79  9  619  U  13.56 
50  5  561 U  9.05  5 1480 E  18.42  8.5  714 U  13.72 Int. J. Environ. Res. Public Health 2009, 6          
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Table 2. Cont. 
53  13  587  A 15.94  16.67  692  A 21.08  19  1740  U 36.15 
55 0.67 34.5  U  1.10  0.67 30.3  A  0.69  1.5  69  A  1.96 
60  10           10  335  A  10.50  15  596  A  16.74 
67 16.67 570  A  18.18  26.33 570  A  29.98  12.5  1020  U  21.15 
68  8.67           2.67  565  E  6.76  0  1490  E  20.42 
70  0           6.67  789  U  12.23  12.5  1020  U  21.04 
74 8 322  A  10.46  8 618  U  12.97  8  420  A  7.63 
75  10           10  870  U  16.88  10  1200  E  19.06 
81  13.33  362 A  15.49  13 534 A  16.35  15  552 A  17.80 
82  20  1430  U 30.81  12.33  388  A 14.32  8 388  A 10.03 
84  10           5  31.8  A  5.38  0.5  129  E  1.42 
87 12 865 U  18.52  10 871 U  17.94  5  1010  E  16.74 
88  3  582 U  5.88  10 671 U  14.44  10  981 U  17.72 
93  4           4  1180  E  14.28  4          
95  20           10  398  A  12.76  4  379  E  7.75 
97  7.33  506 U  11.45  10 314 A  11.22  12.5 382 A  13.01 
99 7.33 863  U  14.03  1.33  0  A  1.33  0  0  A  0.00 
100  33.33  1760  U  48.64  11  829  U  17.99  0          
102  7.33  1770  E  23.86  9.33  1420  E  25.27  16          
105 4  490 E  8.45  2.83  138 U  3.95  2  294 E  4.37 
106  10 315 A  11.28  10 728 U  14.56  10  910 U  16.78 
108  3.67 345  U  6.31  4.33 723  E  10.49  6  342  A  9.16 
109 7  473 U  11.66  0.33  776 E  7.52  0  289 E  2.47 
114  0  11.3  A 0.12  0 0  A 0.00  0  0  A 0.00 
115  0 826  E  5.74  0 331  E  4.20  0  367  E  3.02 
116  8  1970 E  22.07  1.83 860  E  8.90  10  1100 E  19.71 
 
If it is desired to use a more robust adjustment method, as in Dukic et al. [1] we show a way to 
correct for under-reporting (or over-reporting) based on the average of discrepancies of all women in 
their corresponding class for that trimester. For example, for a woman “X” who is an under-reporter in 
trimester  j, if the average discrepancy between cotinine-based and self-reported cigarettes for all 
under-reporters in that trimester is 5, the correction would add to the self-report of woman X a term 
based on those 5 cigarettes. The averages of all correction amounts within each of the categories are 
summarized in Table 3.  
 
Table 3. Average numbers of adjusted cigarettes in each category over trimesters using 
group-correction method.  
Method Trimester 
Category 
over 
reporter
accurate 
reporter 
under 
reporter 
extreme 
under 
reporter 
MC 1  - 1.70  6.38  9.07 
MC 2  -3.54  1.75  6.77  8.56 
MC 3  - 1.21  6.65  7.75 
Det 1     1.36  5.69  8.32 
Det 2  -3.67  1.49  6.07  7.84 
Det 3     0.73  6.06  7.09 Int. J. Environ. Res. Public Health 2009, 6          
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3.1. Sensitivity Analysis 
 
We now examine how much our results would change if we consider alternative distributions in our 
Monte Carlo scheme. Although the distributions we used were based on extensive expertise of one of 
the co-authors in modeling the metabolism of pregnancy smoking, and on the review of literature [25-
29], the fact that little is known about cotinine metabolism during pregnancy prompts us to perform a 
sensitivity analysis to a range of average values for cotinine half-life and the amount of urinary 
cotinine produced by a cigarette. In particular, the observed ratios of cotinine level and weighted self-
report (the actual numbers we would get if we assume self-report is correct and cigarettes are 
uniformly distributed) in our data set are quite variable (they are summarized for each category in each 
trimester in Table 4): the lowest ratio for accurate reporters is 201 ng/mL, which is almost twice the 
amount of cotinine per cigarette per mL of urine usually assumed. This discrepancy may imply that the 
women in our sample are under-reporting routinely, or that the parameter values we use are perhaps 
not the most appropriate ones for pregnancy metabolism. To address this, we varied the mean for 
cotinine concentration per cigarette (originally assumed 100 ng/mL), and mean half-life of cotinine 
(originally assumed 9 hours) to see how much better or worse the agreement between self-report and 
cotinine would get.  
 
Table 4. The ratio is the women’s cotinine levels divided by their weighted number of self-
reported cigarettes. This ratio shows how much of urinary cotinine a cigarette produces 
according to women’s self-reports. This table shows the means and the standard deviation 
for each classification in each trimester. 
Category 
Trimester 1   Trimester 2   Trimester 3 
Mean 
ratio 
SD ratio 
Mean 
ratio 
SD ratio 
Mean 
ratio 
SD 
ratio 
Over reporter  -  -  16.24  -  -  - 
Accurate reporter  309.79  251.84  278.01  153.03  207.21  152.77 
Under reporter  1005.53  2486.65  577.44  579.49  895.17  1002.75
Extreme under 
reporter 7829.90  21275.18 4740.71  10678.09 2169.90  3019.95
Total 2883.77  11869.41 1434.85  5272.85  1085.01  1941.18
 
Changing the average half-life of urinary cotinine had almost no impact on the classification (see 
Table 5). However, adjusting the mean of urinary cotinine a cigarette produces did. As shown in Table 
6, using 100 ng/mL (corresponding roughly to using the means 12.5 and 8 for blood cotinine per 
cigarette concentration and blood-to-urine conversion factor distributions, respectively) 29 out of 128 
(22.7 %) women’s observations are classified as either over-reporters or accurate reporters. Using  
150 ng/mL (corresponding approximately to the means 12.5 for blood cotinine and 12 for urine 
conversion factor), all of women’s observations that were classified as under-reporters before are now 
classified as either accurate or even in some cases over-reporters. Assuming that a cigarette produces 
300 ng/mL (means 12.5 for the blood cotinine and 24 for urine conversion factor) urinary cotinine, Int. J. Environ. Res. Public Health 2009, 6          
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75% of visits get classified as either over or accurate reporters. Thus using 150 ng/mL seems to give us 
overall the most balanced results. Clearly, expert opinion and experimental information as summarized 
by the Monte Carlo distributions are crucial for accuracy in calibration studies such as ours. We carry 
out this sensitivity analysis simply to underline the delicate balance between self-report and cotinine 
and the natural underlying variability. Identical findings were obtained in the sensitivity analysis in the 
deterministic approach of Dukic et al. [1]. 
 
Table 5. The average numbers of adjusted cigarettes in each category over trimesters, 
under different values of cotinine half-life. 
Trimester 
  
Category 
Half - 
life 
mean 
over 
reporter 
accurate 
reporter 
under 
reporter 
extreme 
under 
reporter 
1 5  hours  -  1.65 6.16 9.14 
2 5  hours  -  1.41 6.81 8.60 
3 5  hours  -  1.10 6.88 7.92 
1 20  hours -  1.76 6.87 8.75 
2 20  hours  -3.47 1.84 6.46 8.88 
3 20  hours -  1.41 5.79 8.42 
 
Table 6. The number of women classified into each group in each trimester, using different 
values of urinary cotinine a cigarette produces. Rows 1-3 use 100 ng/mL, rows 4-6 use  
150 ng/mL, and rows 7-9 use 300 ng/mL. 
Cotinine/Cigarette 
(ng/mL) 
Trimester
Over 
reporters
Accurate 
reporters
Under 
reporters 
Extreme 
under 
reporters 
100  1  0  10 16 12 
100  2  1  17 15 12 
100  3  0  13 13 15 
150  1  0 21  10 7 
150  2  1 25 8 11 
150  3  2 15  15 9 
300  1  1 30 5  2 
300  2  1 35 5  4 
300  3  2 30 5  4 
 
4. Discussion 
 
We present a new approach for calibrating self-reported smoking using biologic assays of cotinine, 
based on deviations from what is considered to be an average cotinine amount per cigarette in urine Int. J. Environ. Res. Public Health 2009, 6          
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over the course of pregnancy [20], while integrating multiple sources of information and heterogeneity 
among women with respect to exposure metabolism. We have extended the methods from Dukic et al. 
[1] to account for heterogeneity of women and provide classification and adjustment under uncertainty. 
The uncertainty in non-linear models, such as this one, not only result in larger variation in the results, 
but may also change the average values used to adjust the self-reports.  
The MC method is similar in spirit to the method of Dukic et al. [1]. The main difference between 
the two is that the current method results in the Monte Carlo sample of classifications for each woman, 
rather than a single deterministic classification. This sample of classifications reflects the metabolic 
variability in each trimester for every woman. The Monte Carlo approach thus allows us (1) to 
determine how much the adjustment of self-report will vary once the heterogeneity among women 
(both in terms of metabolic quantities and trimester) is accounted for, and (2) to perform the most 
likely classification under conditions of metabolic uncertainty. The new MC method is expected to be 
more stable than the original method – a larger percentage of women would be classified as accurate 
reporters since the added variability protects from possible overcorrecting of self-reported measures 
over time.  
Besides accounting for heterogeneity in metabolic parameters over time during pregnancy, there are 
still possible improvements to our approach. For example, systematic differences in times of urination 
and fluid intake (and thus urine volume) among women remain an important source of variability 
which could confound the effect of metabolic differences among women. Thus, future studies should 
pay particular attention to gathering information on these habits along with the biological 
measurements such as cotinine when trying to assess smoking exposure. If this could be done, our 
methods could be extended in a straight-forward manner to accommodate this extra information and 
yield more precise woman-specific adjustments. 
In spite of the limited size, the FHDP study with its rich smoking exposure component has provided 
us with a unique opportunity to examine some of these questions about the relationship between self-
report and biological measures. However, it is clear that small sample size is a limitation; in particular, 
studies with only one visit during pregnancy which has both self-report and urinary measurement 
would not provide good insight into the true smoking behavior over time during pregnancy. Although 
data on pregnant smokers are in general hard to collect, a larger and better designed dataset with 
additional repeated measurements of self-report and serum or urinary cotinine, along with detailed 
timing of voiding during the past three days, all on a larger sample, would almost certainly be very 
informative. For example, additional repeated measurements would give us a better sense of the 
pattern of the metabolism heterogeneity over time. In addition, in a sample with larger demographic 
and metabolic heterogeneity (due for example to a wider distribution in age, BMI, or greater genetic 
diversity), it is likely that much more variability over time and between women would be captured by 
the MC method. We hope that this novel approach to classification and calibration of self-reports 
based on biological measures can shed new light on measurement of smoking exposure in general, and 
not just during pregnancy, as they are applied to larger datasets.  
There are several other limitations to our approach. One is the inability to account for individual 
variation in smoking topography, that is, how much nicotine is absorbed systemically from each 
cigarette. Environmental tobacco smoke exposure might also be considered a potential confounder, 
although cotinine levels from this source are usually insignificant compared to active smoking. Thus Int. J. Environ. Res. Public Health 2009, 6          
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there are important potential confounders with metabolic differences, which will remain until better 
data on them are collected in future studies. Indeed, it may seem that the wide range of discrepancies 
between common assumptions and our findings implies that either most of the mothers in our rather 
homogenous sample are inaccurate reporters, or that the assumptions such as blood-urine cotinine 
conversion factor or cotinine per cigarette levels are simply not appropriate. We unfortunately cannot 
separate the assumptions from misreporting given our data without relying on further assumptions. 
More elaborate studies about smoking topography, as well as cotinine metabolism and excretion 
during pregnancy are needed to make progress with respect to this issue.  
The methods proposed in this paper are another step towards more sophisticated methodology for 
integrating self-reported and biologic estimates of exposure, which are not only able to incorporate 
heterogeneity among women but also various sources of uncertainty in measurements and data 
collection. Estimating exposure more precisely enhances the capacity for rigorously testing a variety of 
hypotheses, as well as time and threshold effects, all of which are critical to establishing causality in 
exposure-behavior relationship. In future studies, we plan to test whether the combined method 
proposed here adds incremental value to prediction of behavioral outcomes in exposed offspring, over 
and above that based on self-report and/or cotinine alone.  
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Appendix: Calculations of Uncertainty in Cotinine-Nicotine Cigarette Relationship 
 
We used the following values for the distributions in our Monte Carlo simulation: 
 
Cotinine blood half-life: Normally distributed with mean 527 min, and standard deviation of 100 min. 
Ratio Blood-Urine: Normally distributed with mean 8 and standard deviation of 2 
Blood cotinine/cigarette: Normally distributed with mean 8, and standard deviation of 0.5. 
 
We derived these values following a set of equilibrium cotinine clearance equations and parameter 
ranges given to us by Prof. Benowitz’ lab:  
 
Nicotine intake per cigarette = [Cotinine concentration] x [Cotinine clearance] / [f] 
which is equivalent to: 
Blood cotinine concentration per cigarette = (Nicotine per cigarette) / (Cotinine clearance), Int. J. Environ. Res. Public Health 2009, 6          
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where: 
  Nicotine per cigarette is distributed normally with mean 1.2 mg/cig and range of 0.5 to 2. 
  Cotinine clearance per kg of body weight has mean of 1.46 ranging from 0.9 to 2. 
  f is a scalar with mean 0.78 and ranging from 0.69 to 0.87.  
 
In our calculations we assume the average body weight is 80 kilograms. 
 
Urine cotinine levels that are used to define smokers in the paper are 30 ng/mL. Notice that historically 
these values were different. For non-pregnant population, in Jarvis et al. UK study from the 80's the 
blood cotinine level used to define smokers was 14 ng/mL (implying urine level of 112 ng/mL). 
However, in a more recent study, Benowitz and colleagues have found the urinary cutoff-level of less 
than 0.2 ng/mL [28]. These differences are primarily due to changes in environmental tobacco smoke 
exposure that have resulted from changes in lifestyle over time and differences in cultural habits as 
well as the introduction of Indoor Air regulation in the early 90's. Time and cultural trend must be 
taken into account in studies of smoking nondisclosure during pregnancy: the study we are using was 
done in the US in mid 90's. It is also important to take into account the number of smokers in the 
household, since their cutoff for ETS will most likely need to be higher. Notice, however, that for our 
purposes identifying the exact cutoff for defining a smoker is not very relevant. Using a cutoff lower 
than 30 ng/mL would have resulted in an inclusion of a subset of women who did not report being a 
smoker but whose true exposure would be very low (estimated at most 0.5 cigarette per day). This 
would have negligible effect on our results. 
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